Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
US9012214B2 · kind B2 · utility
7Cited by
11References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 4, 2010 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Jan 16, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a recombinant measles virus expressing a heterologous amino acid sequence derived from an antigen of a determined RNA virus, the recombinant measles virus being capable of eliciting a humoral and/or cellular immune response against measles virus or against the RNA virus or against both measles virus and against the RNA virus. It also relates to the use of the recombinant measles virus for the preparation of immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.